A decisive technical leap forward for personalized medicine to treat mitochondrial diseases
Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to severe conditions. Expression of mtDNA is a prerequisite for ATP production by oxidative phosphorylation. Individual cells contain many hundred copies of mtDNA and mutated mtDNA...
| Published in: | EMBO Molecular Medicine |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-04-01
|
| Online Access: | https://doi.org/10.1038/s44321-025-00232-4 |